WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China
WuXi Biologics announced that it has entered into an equity agreement with Pfizer China to acquire its state-of-the-art biologics manufacturing facilities as well as its labor force in…
Read More...
Read More...
